GZMB and breast cancer: Interestingly, estrogen treatment (E2) in SkBr3 breast cancer and HepG2 hepatocarcinoma cells increased the expression of miR-144 through the PI3K/ERK/Elk1 transduction pathway [39], which may serve as a positive activator of GRβ.